Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ENvue Medical (FEED) Shares Outstanding (Weighted Average) (2017 - 2025)

Historic Shares Outstanding (Weighted Average) for ENvue Medical (FEED) over the last 12 years, with Q3 2025 value amounting to $858434.0.

  • ENvue Medical's Shares Outstanding (Weighted Average) rose 20623.58% to $858434.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $858434.0, marking a year-over-year increase of 20623.58%. This contributed to the annual value of $269848.0 for FY2024, which is 6960.37% up from last year.
  • As of Q3 2025, ENvue Medical's Shares Outstanding (Weighted Average) stood at $858434.0, which was up 20623.58% from $484566.0 recorded in Q2 2025.
  • Over the past 5 years, ENvue Medical's Shares Outstanding (Weighted Average) peaked at $26.1 million during Q3 2021, and registered a low of $25312.0 during Q2 2024.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $1.4 million (2022), whereas its average is $4.7 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first plummeted by 9847.73% in 2024, then skyrocketed by 181437.26% in 2025.
  • ENvue Medical's Shares Outstanding (Weighted Average) (Quarter) stood at $1.3 million in 2021, then grew by 12.84% to $1.4 million in 2022, then crashed by 88.79% to $159105.0 in 2023, then surged by 69.6% to $269848.0 in 2024, then surged by 218.12% to $858434.0 in 2025.
  • Its Shares Outstanding (Weighted Average) was $858434.0 in Q3 2025, compared to $484566.0 in Q2 2025 and $626150.0 in Q1 2025.